Nuvama analyst Shrikant Akolkar initiates coverage on Shilpa Medicare (SLPA:IN) with a Buy rating and a price target of INR1,200.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE